26 related articles for article (PubMed ID: 38576392)
1. Lactylproteome analysis indicates histone H4K12 lactylation as a novel biomarker in triple-negative breast cancer.
Cui Z; Li Y; Lin Y; Zheng C; Luo L; Hu D; Chen Y; Xiao Z; Sun Y
Front Endocrinol (Lausanne); 2024; 15():1328679. PubMed ID: 38779451
[TBL] [Abstract][Full Text] [Related]
2. [Extraction and isolation of histones from paraffin-embedded tissues and quantitative analysis of post-translational modifications].
Tian S; Liu R; Qian X; Guo X; Zhang K
Se Pu; 2021 Oct; 39(10):1094-1101. PubMed ID: 34505431
[TBL] [Abstract][Full Text] [Related]
3. Pathology Tissue-quantitative Mass Spectrometry Analysis to Profile Histone Post-translational Modification Patterns in Patient Samples.
Noberini R; Uggetti A; Pruneri G; Minucci S; Bonaldi T
Mol Cell Proteomics; 2016 Mar; 15(3):866-77. PubMed ID: 26463340
[TBL] [Abstract][Full Text] [Related]
4. PAT-H-MS coupled with laser microdissection to study histone post-translational modifications in selected cell populations from pathology samples.
Noberini R; Longuespée R; Richichi C; Pruneri G; Kriegsmann M; Pelicci G; Bonaldi T
Clin Epigenetics; 2017; 9():69. PubMed ID: 28702092
[TBL] [Abstract][Full Text] [Related]
5. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
Cuomo A; Moretti S; Minucci S; Bonaldi T
Amino Acids; 2011 Jul; 41(2):387-99. PubMed ID: 20617350
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative and Antimigration Activities of Fluoro-Neplanocin A via Inhibition of Histone H3 Methylation in Triple-Negative Breast Cancer.
Byun WS; Kim WK; Yoon JS; Jarhad DB; Jeong LS; Lee SK
Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32244385
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Pattern of hPTMs by Mass Spectrometry-Based Proteomics with Implications for Triple-Negative Breast Cancer.
Liu C; Xu M; Li W; Cao X; Wang Y; Chen H; Zhang T; Lu M; Xie H; Chen Y
J Proteome Res; 2024 Apr; 23(4):1495-1505. PubMed ID: 38576392
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in mass spectrometry analysis of histone post-translational modifications: potential clinical impact of the PAT-H-MS approach.
Bonaldi T; Noberini R
Expert Rev Proteomics; 2016; 13(3):245-50. PubMed ID: 26822344
[TBL] [Abstract][Full Text] [Related]
9. Function and Mechanism of Novel Histone Posttranslational Modifications in Health and Disease.
Xu H; Wu M; Ma X; Huang W; Xu Y
Biomed Res Int; 2021; 2021():6635225. PubMed ID: 33763479
[TBL] [Abstract][Full Text] [Related]
10. Biochemical systems approaches for the analysis of histone modification readout.
Soldi M; Bremang M; Bonaldi T
Biochim Biophys Acta; 2014 Aug; 1839(8):657-68. PubMed ID: 24681439
[TBL] [Abstract][Full Text] [Related]
11. Novel histone post-translational modifications in Alzheimer's disease: current advances and implications.
Qin Y; Yang P; He W; Li D; Zeng L; Li J; Zhou T; Peng J; Cao L; Huang W
Clin Epigenetics; 2024 Mar; 16(1):39. PubMed ID: 38461320
[TBL] [Abstract][Full Text] [Related]
12. Analytical strategies used to identify the readers of histone modifications: A review.
Wang Y; Han Y; Fan E; Zhang K
Anal Chim Acta; 2015 Sep; 891():32-42. PubMed ID: 26388362
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
